# Clinical Efficacy of Potassium Canrenoate in Sinus Rhythm Restoration Among Patients With Atrial Fibrillation.

> **NCT03536806** · PHASE4 · UNKNOWN · sponsor: **National Institute of Cardiology, Warsaw, Poland** · enrollment: 80 (estimated)

## Conditions studied

- Atrial Fibrillation, Paroxysmal

## Interventions

- **DRUG:** Saline 0.9%
- **DRUG:** Canrenone

## Key facts

- **NCT ID:** NCT03536806
- **Lead sponsor:** National Institute of Cardiology, Warsaw, Poland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06
- **Primary completion:** 2019-12
- **Final completion:** 2020-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2018-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03536806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03536806, "Clinical Efficacy of Potassium Canrenoate in Sinus Rhythm Restoration Among Patients With Atrial Fibrillation.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03536806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*